Skip to content

Effect of intrauterine perfusion of platelet-rich plasma on patients with recurrent implantation failure and endometriosis: a prospective and non-randomized controlled study

Effect of intrauterine perfusion of platelet-rich plasma on patients with recurrent implantation failure and endometriosis: a prospective and non-randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064516
Enrollment
Unknown
Registered
2022-10-10
Start date
2022-10-08
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with recurrent implantation failure and endometriosis

Interventions

Experimental group:intrauterine perfusion of platelet-rich plasma
Conrol group:intrauterine perfusion of HCG

Sponsors

The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Age 20-40 years old; 2. Meet the diagnostic criteria for repeated implantation failure: embryo implantation failure for 3 or more consecutive embryo transfer cycles (including fresh and frozen transfer cycles), accumulatively transfer at least 4 high-quality embryos and fail to achieve clinical pregnancy; 3. Meet the diagnostic criteria of endometriosis; 4. Patients have reproductive requirements, voluntarily participate in this study and sign the informed consent (see informed consent).

Exclusion criteria

Exclusion criteria: 1. Unilateral or bilateral hydrosalpinx, uterine cavity effusion; 2. Those with organic lesions (endometrial polyps) and intrauterine adhesions in the uterus and uterine cavity, and endometrial tuberculosis; 3. The woman should not be pregnant or the original disease will be exacerbated after pregnancy, and serious cases will threaten life safety, such as severe heart disease, nephritis, hepatitis, etc.; 4. The woman's genitals are severely underdeveloped or deformed; she suffers from acute infection or sexually transmitted disease. Suffering from severe genetic, physical or mental illness; 5. Either party has serious bad habits, cognitive impairment, exposure to teratogenic doses of radiation, poisons, drugs, and due to the period of action or abnormal chromosomal karyotype.

Design outcomes

Primary

MeasureTime frame
the implantation rate;

Secondary

MeasureTime frame
the clinical pregnancy rate;the biochemical pregnancy rate;the early miscarriage rate;the ongoing pregnancy rate;

Countries

China

Contacts

Public ContactLi Ying

The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University

1207552176@qq.com+86 15013613327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026